ALX Oncology Holdings Inc. (ALXO)

NMS – Цена в реальном времени. Валюта: USD

2.01

+0.08 (4.15%)

Рынок открыт: Aug 12, 2026, 3:43 PM EDT

1.96

+0.03 (1.55%)

Предыдущая сессия: Aug 11, 2026, 7:34 PM EDT

11.08.2026

Is ALX Oncology Holdings (ALXO) Stock Outpacing Its Medical Peers This Year?

Here is how ALX Oncology Holdings Inc. (ALXO) and Medpace (MEDP) have performed compared to their sector so far this year.

06.08.2026

ALX Oncology Reports Second Quarter 2026 Financial Results and Provides Corporate Update

– On track for mid-2027 topline data readout from 80 patients in the Phase 2 ASPEN-09-Breast clinical trial evaluating evorpacept in combination with trastuzumab and chemotherapy in HER2-positive metastatic breast cancer – – Presented encouraging Phase 1b/2 breast cancer data at ESMO Breast Cancer 2026 that further validate a biomarker-driven development strategy for evorpacept – – Strong enrollment momentum in Phase 1 clinical trial of ALX2004 in EGFR expressing solid tumors with initial safety data on-track for 2H 2026 – – Strengthened leadership team with the appointments of Scott Garland as Chairman of the Board of Directors and Michael Listgarten as General Counsel – SOUTH SAN FRANCISCO, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc. ("ALX Oncology," Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients' lives, today reported financial results for the second quarter ended June 30, 2026, and provided a corporate update.

Видео

No Data

There is no data to display

Пресс-релизы

06.08.2026

ALX Oncology Holdings Inc. (ALXO)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

ALX Oncology Holdings Inc. (ALXO)

Is ALX Oncology Holdings (ALXO) Stock Outpacing Its Medical Peers This Year?

ALX Oncology Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Видео

No Data

Пресс-релизы

ALX Oncology Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Is ALX Oncology Holdings (ALXO) Stock Outpacing Its Medical Peers This Year?

ALX Oncology Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Видео

No Data

Пресс-релизы

ALX Oncology Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Search stocks

ALX Oncology Holdings Inc. (ALXO)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

ALX Oncology Holdings Inc. (ALXO)

Is ALX Oncology Holdings (ALXO) Stock Outpacing Its Medical Peers This Year?

ALX Oncology Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Видео

No Data

Пресс-релизы

ALX Oncology Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Is ALX Oncology Holdings (ALXO) Stock Outpacing Its Medical Peers This Year?

ALX Oncology Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Видео

No Data

Пресс-релизы

ALX Oncology Reports Second Quarter 2026 Financial Results and Provides Corporate Update